D J Margolis. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Etretinate/administration & dosageEtretinate/adverse effectsHumansKeratolytic Agents/administration & dosageKeratolytic Agents/adverse effectsOsteoporosis/chemically inducedTime Factors
Substances： See more » Keratolytic AgentsEtretinate
Year: 1996 PMID： 8651730 DOI： 10.1001/archderm.1996.03890300143027
Source DB: PubMed Journal: Arch Dermatol ISSN： 0003-987X